Mendla K - Search Results

1

Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders.

Cereda E, Brambilla A, Ezhaya A, Gaida W, Mendla K, Monferini E, Pitsikas N, Schiavi GB, Sagrada A. Cereda E, et al. Among authors: mendla k. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):179-83. doi: 10.1007/BF03188919. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867659

2

WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties.

Ensinger HA, Doods HN, Immel-Sehr AR, Kuhn FJ, Lambrecht G, Mendla KD, Müller RE, Mutschler E, Sagrada A, Walther G, et al. Ensinger HA, et al. Among authors: mendla kd. Life Sci. 1993;52(5-6):473-80. doi: 10.1016/0024-3205(93)90304-l. Life Sci. 1993. PMID: 8441328

3

Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain.

Müller DM, Mendla K, Farber SA, Nitsch RM. Müller DM, et al. Among authors: mendla k. Life Sci. 1997;60(13-14):985-91. doi: 10.1016/s0024-3205(97)00038-6. Life Sci. 1997. PMID: 9121365

4

Cloning and functional characterization of a human A1 adenosine receptor.

Libert F, Van Sande J, Lefort A, Czernilofsky A, Dumont JE, Vassart G, Ensinger HA, Mendla KD. Libert F, et al. Among authors: mendla kd. Biochem Biophys Res Commun. 1992 Sep 16;187(2):919-26. doi: 10.1016/0006-291x(92)91285-x. Biochem Biophys Res Commun. 1992. PMID: 1530647

5

Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo.

Rossner S, Mendla K, Schliebs R, Bigl V. Rossner S, et al. Among authors: mendla k. Eur J Neurosci. 2001 Apr;13(8):1644-8. doi: 10.1046/j.0953-816x.2001.01525.x. Eur J Neurosci. 2001. PMID: 11328358

6

Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation.

Rossner S, Beck M, Stahl T, Mendla K, Schliebs R, Bigl V. Rossner S, et al. Among authors: mendla k. Eur J Neurosci. 2000 Sep;12(9):3191-200. doi: 10.1046/j.1460-9568.2000.00211.x. Eur J Neurosci. 2000. PMID: 10998103

7

Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C.

Walter J, Grünberg J, Capell A, Pesold B, Schindzielorz A, Citron M, Mendla K, George-Hyslop PS, Multhaup G, Selkoe DJ, Haass C. Walter J, et al. Among authors: mendla k. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5349-54. doi: 10.1073/pnas.94.10.5349. Proc Natl Acad Sci U S A. 1997. PMID: 9144240 Free PMC article.

8

Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation.

Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM, Selkoe DJ, Romig H, Mendla K, Haass C. Steiner H, et al. Among authors: mendla k. J Biol Chem. 1998 Nov 27;273(48):32322-31. doi: 10.1074/jbc.273.48.32322. J Biol Chem. 1998. PMID: 9822712 Free article.

9

Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.

Golombowski S, Müller-Spahn F, Romig H, Mendla K, Hock C. Golombowski S, et al. Among authors: mendla k. Neurosci Lett. 1997 Apr 11;225(3):213-5. doi: 10.1016/s0304-3940(97)00228-0. Neurosci Lett. 1997. PMID: 9147408

10

Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease.

Mendla K, Baumkötter J, Rosenau C, Ulrich-Bott B, Cantz M. Mendla K, et al. Biochem J. 1988 Feb 15;250(1):261-7. doi: 10.1042/bj2500261. Biochem J. 1988. PMID: 2451509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters